U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Mania

MedGen UID:
648676
Concept ID:
C0564408
Finding
Synonyms: Hypomania; Hypomanic; Manic; Manic Mood; Manic mood
SNOMED CT: Manic mood (405273008)
 
HPO: HP:0100754

Definition

A state of abnormally elevated or irritable mood, arousal, and/or energy levels. [from HPO]

Conditions with this feature

Major affective disorder 1
MedGen UID:
377615
Concept ID:
C1852197
Mental or Behavioral Dysfunction
Bipolar disorder is a mental health condition that causes extreme shifts in mood, energy, and behavior. This disorder most often appears in late adolescence or early adulthood, although symptoms can begin at any time of life.\n\nPeople with bipolar disorder experience both dramatic "highs," called manic episodes, and "lows," called depressive episodes. These episodes can last from hours to weeks, and many people have no symptoms between episodes.\n\nManic episodes are characterized by increased energy and activity, irritability, restlessness, an inability to sleep, and reckless behavior. Some people with bipolar disorder experience hypomanic episodes, which are similar to but less extreme than manic episodes.\n\nBipolar disorder often occurs with other mental health conditions, including anxiety disorders (such as panic attacks), behavioral disorders (such as attention-deficit/hyperactivity disorder), and substance abuse.\n\nDepressive episodes are marked by low energy and activity, a feeling of hopelessness, and an inability to perform everyday tasks. People with bipolar disorder often have repeated thoughts of death and suicide, and they have a much greater risk of dying by suicide than the general population.\n\nManic and depressive episodes can include psychotic symptoms, such as false perceptions (hallucinations) or strongly held false beliefs (delusions). Mixed episodes, which have features of manic and depressive episodes at the same time, also occur in some affected individuals.\n\nBipolar disorder is classified into several types based on the mood changes that occur. Bipolar I involves manic episodes, which can be accompanied by psychotic symptoms, and hypomanic or depressive episodes. Bipolar II involves hypomanic episodes and depressive episodes. Cyclothymic disorder involves hypomanic episodes and depressive episodes that are typically less severe than those in bipolar I or bipolar II.
Huntington disease-like 1
MedGen UID:
355137
Concept ID:
C1864112
Disease or Syndrome
Genetic prion disease generally manifests with cognitive difficulties, ataxia, and myoclonus (abrupt jerking movements of muscle groups and/or entire limbs). The order of appearance and/or predominance of these features and other associated neurologic and psychiatric findings vary. The three major phenotypes of genetic prion disease are genetic Creutzfeldt-Jakob disease (gCJD), fatal familial insomnia (FFI), and Gerstmann-Sträussler-Scheinker (GSS) syndrome. Although these phenotypes display overlapping clinical and pathologic features, recognition of these phenotypes can be useful when providing affected individuals and their families with information about the expected clinical course. The age at onset typically ranges from 50 to 60 years. The disease course ranges from a few months in gCJD and FFI to a few (up to 4, and in rare cases up to 10) years in GSS syndrome.

Professional guidelines

PubMed

Nierenberg AA, Agustini B, Köhler-Forsberg O, Cusin C, Katz D, Sylvia LG, Peters A, Berk M
JAMA 2023 Oct 10;330(14):1370-1380. doi: 10.1001/jama.2023.18588. PMID: 37815563
Goes FS
BMJ 2023 Apr 12;381:e073591. doi: 10.1136/bmj-2022-073591. PMID: 37045450
Salvi V, Ribuoli E, Servasi M, Orsolini L, Volpe U
Medicina (Kaunas) 2021 May 10;57(5) doi: 10.3390/medicina57050466. PMID: 34068605Free PMC Article

Recent clinical studies

Etiology

Du Z, Guo S, Sun Y, Zhou Q, Jiang Y, Shen Y, Zhu H, Zhou Z, Zhou H
J Affect Disord 2023 Nov 1;340:607-615. Epub 2023 Aug 18 doi: 10.1016/j.jad.2023.08.098. PMID: 37598719
Arnold I, Dehning J, Grunze A, Hausmann A
Medicina (Kaunas) 2021 Jun 8;57(6) doi: 10.3390/medicina57060587. PMID: 34201098Free PMC Article
Tondo L, Vázquez GH, Baldessarini RJ
Curr Neuropharmacol 2017 Apr;15(3):353-358. doi: 10.2174/1570159X14666160606210811. PMID: 28503106Free PMC Article
Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP
J Affect Disord 2015 Jan 15;171:39-47. Epub 2014 Sep 23 doi: 10.1016/j.jad.2014.09.016. PMID: 25285897
Jacobowski NL, Heckers S, Bobo WV
J Psychiatr Pract 2013 Jan;19(1):15-28. doi: 10.1097/01.pra.0000426324.67322.06. PMID: 23334676

Diagnosis

Cotovio G, Oliveira-Maia AJ
Transl Psychiatry 2022 Jan 24;12(1):29. doi: 10.1038/s41398-022-01786-4. PMID: 35075120Free PMC Article
Tondo L, Vázquez GH, Baldessarini RJ
Curr Neuropharmacol 2017 Apr;15(3):353-358. doi: 10.2174/1570159X14666160606210811. PMID: 28503106Free PMC Article
Dubovsky SL
Continuum (Minneap Minn) 2015 Jun;21(3 Behavioral Neurology and Neuropsychiatry):737-55. doi: 10.1212/01.CON.0000466663.28026.6f. PMID: 26039851
Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP
J Affect Disord 2015 Jan 15;171:39-47. Epub 2014 Sep 23 doi: 10.1016/j.jad.2014.09.016. PMID: 25285897
Jacobowski NL, Heckers S, Bobo WV
J Psychiatr Pract 2013 Jan;19(1):15-28. doi: 10.1097/01.pra.0000426324.67322.06. PMID: 23334676

Therapy

Fountoulakis KN, Tohen M, Zarate CA Jr
Eur Neuropsychopharmacol 2022 Jan;54:100-115. doi: 10.1016/j.euroneuro.2021.10.003. PMID: 34980362Free PMC Article
Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Nomura I, Hatano M, Iwata N
Mol Psychiatry 2022 Feb;27(2):1136-1144. Epub 2021 Oct 12 doi: 10.1038/s41380-021-01334-4. PMID: 34642461Free PMC Article
Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Mishima K, Iwata N
Mol Psychiatry 2021 Aug;26(8):4146-4157. Epub 2020 Nov 11 doi: 10.1038/s41380-020-00946-6. PMID: 33177610Free PMC Article
Fagiolini A, Coluccia A, Maina G, Forgione RN, Goracci A, Cuomo A, Young AH
CNS Drugs 2015 Sep;29(9):725-40. doi: 10.1007/s40263-015-0275-6. PMID: 26369921
Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, Purgato M, Spineli LM, Goodwin GM, Geddes JR
Lancet 2011 Oct 8;378(9799):1306-15. Epub 2011 Aug 16 doi: 10.1016/S0140-6736(11)60873-8. PMID: 21851976

Prognosis

Connors MH
Acta Neuropsychiatr 2023 Apr;35(2):96-103. Epub 2022 Nov 14 doi: 10.1017/neu.2022.28. PMID: 36373500
Molnar MZ, Eason JD, Gaipov A, Talwar M, Potukuchi PK, Joglekar K, Remport A, Mathe Z, Mucsi I, Novak M, Kalantar-Zadeh K, Kovesdy CP
Transpl Int 2018 May;31(5):554-565. Epub 2018 Feb 27 doi: 10.1111/tri.13127. PMID: 29405487Free PMC Article
Fang F, Sun H, Wang Z, Ren M, Calabrese JR, Gao K
CNS Drugs 2016 Sep;30(9):845-67. doi: 10.1007/s40263-016-0352-5. PMID: 27372312
Santos CO, Caeiro L, Ferro JM, Figueira ML
Cerebrovasc Dis 2011;32(1):11-21. Epub 2011 May 11 doi: 10.1159/000327032. PMID: 21576938
Griswold KS, Pessar LF
Am Fam Physician 2000 Sep 15;62(6):1343-53, 1357-8. PMID: 11011863

Clinical prediction guides

Popiolek K, Bejerot S, Landén M, Nordenskjöld A
JAMA Netw Open 2022 Jun 1;5(6):e2218330. doi: 10.1001/jamanetworkopen.2022.18330. PMID: 35737387Free PMC Article
Wozniak J, DiSalvo M, Farrell A, Vaudreuil C, Uchida M, Ceranoglu TA, Joshi G, Cook E, Faraone SV, Biederman J
BMC Psychiatry 2022 May 3;22(1):314. doi: 10.1186/s12888-022-03943-x. PMID: 35505312Free PMC Article
Patino LR, Klein CC, Strawn JR, Blom TJ, Tallman MJ, Adler CM, Welge JA, DelBello MP
J Child Adolesc Psychopharmacol 2021 Sep;31(7):485-493. Epub 2021 Sep 14 doi: 10.1089/cap.2021.0039. PMID: 34520250Free PMC Article
Tarr GP, Herbison P, de la Barra SL, Glue P
Bipolar Disord 2011 Mar;13(2):125-32. doi: 10.1111/j.1399-5618.2011.00904.x. PMID: 21443566
Young RC, Biggs JT, Ziegler VE, Meyer DA
Br J Psychiatry 1978 Nov;133:429-35. doi: 10.1192/bjp.133.5.429. PMID: 728692

Recent systematic reviews

De Crescenzo F, D'Alò GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N, Kurtulmus A, Tomlinson A, Mitrova Z, Foti F, Del Giovane C, Quested DJ, Cowen PJ, Barbui C, Amato L, Efthimiou O, Cipriani A
Lancet 2022 Jul 16;400(10347):170-184. doi: 10.1016/S0140-6736(22)00878-9. PMID: 35843245
Fountoulakis KN, Tohen M, Zarate CA Jr
Eur Neuropsychopharmacol 2022 Jan;54:100-115. doi: 10.1016/j.euroneuro.2021.10.003. PMID: 34980362Free PMC Article
Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Nomura I, Hatano M, Iwata N
Mol Psychiatry 2022 Feb;27(2):1136-1144. Epub 2021 Oct 12 doi: 10.1038/s41380-021-01334-4. PMID: 34642461Free PMC Article
Pahwa M, Sleem A, Elsayed OH, Good ME, El-Mallakh RS
Curr Psychiatry Rep 2021 Nov 29;23(12):87. doi: 10.1007/s11920-021-01298-w. PMID: 34843030
Pacchiarotti I, Tiihonen J, Kotzalidis GD, Verdolini N, Murru A, Goikolea JM, Valentí M, Aedo A, Vieta E
Eur Neuropsychopharmacol 2019 Apr;29(4):457-470. Epub 2019 Feb 12 doi: 10.1016/j.euroneuro.2019.02.003. PMID: 30770235

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...